Migraine prevalence, disease burden, and the need for preventive therapy
- PMID: 17261680
- DOI: 10.1212/01.wnl.0000252808.97649.21
Migraine prevalence, disease burden, and the need for preventive therapy
Abstract
Objectives: 1) To reassess the prevalence of migraine in the United States; 2) to assess patterns of migraine treatment in the population; and 3) to contrast current patterns of preventive treatment use with recommendations for use from an expert headache panel.
Methods: A validated self-administered headache questionnaire was mailed to 120,000 US households, representative of the US population. Migraineurs were identified according to the criteria of the second edition of the International Classification of Headache Disorders. Guidelines for preventive medication use were developed by a panel of headache experts. Criteria for consider or offer prevention were based on headache frequency and impairment.
Results: We assessed 162,576 individuals aged 12 years or older. The 1-year period prevalence for migraine was 11.7% (17.1% in women and 5.6% in men). Prevalence peaked in middle life and was lower in adolescents and those older than age 60 years. Of all migraineurs, 31.3% had an attack frequency of three or more per month, and 53.7% reported severe impairment or the need for bed rest. In total, 25.7% met criteria for "offer prevention," and in an additional 13.1%, prevention should be considered. Just 13.0% reported current use of daily preventive migraine medication.
Conclusions: Compared with previous studies, the epidemiologic profile of migraine has remained stable in the United States during the past 15 years. More than one in four migraineurs are candidates for preventive therapy, and a substantial proportion of those who might benefit from prevention do not receive it.
Similar articles
-
Probable migraine in the United States: results of the American Migraine Prevalence and Prevention (AMPP) study.Cephalalgia. 2007 Mar;27(3):220-9. doi: 10.1111/j.1468-2982.2006.01275.x. Cephalalgia. 2007. PMID: 17263769
-
Migraine in America Symptoms and Treatment (MAST) Study: Baseline Study Methods, Treatment Patterns, and Gender Differences.Headache. 2018 Oct;58(9):1408-1426. doi: 10.1111/head.13407. Epub 2018 Oct 20. Headache. 2018. PMID: 30341895
-
Patterns of diagnosis and acute and preventive treatment for migraine in the United States: results from the American Migraine Prevalence and Prevention study.Headache. 2007 Mar;47(3):355-63. doi: 10.1111/j.1526-4610.2006.00631.x. Headache. 2007. PMID: 17371352
-
Practice guideline update summary: Pharmacologic treatment for pediatric migraine prevention: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society.Neurology. 2019 Sep 10;93(11):500-509. doi: 10.1212/WNL.0000000000008105. Epub 2019 Aug 14. Neurology. 2019. PMID: 31413170 Free PMC article. Review.
-
The prevalence and burden of migraine and severe headache in the United States: updated statistics from government health surveillance studies.Headache. 2015 Jan;55(1):21-34. doi: 10.1111/head.12482. Headache. 2015. PMID: 25600719 Review.
Cited by
-
Abortive and Prophylactic Therapies to Treat Migraine in Pregnancy: A Review.Cureus. 2024 Oct 4;16(10):e70807. doi: 10.7759/cureus.70807. eCollection 2024 Oct. Cureus. 2024. PMID: 39493026 Free PMC article. Review.
-
The impact of midlife on migraine in women: summary of current views.Womens Midlife Health. 2020 Oct 6;6:11. doi: 10.1186/s40695-020-00059-8. eCollection 2020. Womens Midlife Health. 2020. PMID: 33042563 Free PMC article. Review.
-
Exploring the Hereditary Nature of Migraine.Neuropsychiatr Dis Treat. 2021 Apr 22;17:1183-1194. doi: 10.2147/NDT.S282562. eCollection 2021. Neuropsychiatr Dis Treat. 2021. PMID: 33911866 Free PMC article. Review.
-
Prevalence and risk factors for depression and anxiety among outpatient migraineurs in mainland China.J Headache Pain. 2012 Jun;13(4):303-10. doi: 10.1007/s10194-012-0442-9. Epub 2012 Apr 1. J Headache Pain. 2012. PMID: 22466285 Free PMC article.
-
A Framework for Estimating the Eligible Patient Population for New Migraine Acute Therapies in the United States.Adv Ther. 2021 Oct;38(10):5087-5097. doi: 10.1007/s12325-021-01781-z. Epub 2021 May 31. Adv Ther. 2021. PMID: 34057676 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous